These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion? Gulliford MC; Charlton J; Latinovic R J Hum Hypertens; 2005 Feb; 19(2):111-7. PubMed ID: 15361893 [TBL] [Abstract][Full Text] [Related]
23. [Iatrogenic angioedema: the role of angiotensin converting enzyme inhibitor and angiotensin II receptor blockers]. Roskiewicz F; Andriamanana I; Gras-Champel V; Andrejak M; Massy ZA Nephrol Ther; 2007 Jun; 3(3):89-95. PubMed ID: 17540310 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: a neglected issue in daily practice in Greece. Symvoulakis EK; Kyrmizakis DE; Drivas EI; Bizakis J; Velegrakis GA; Lionis C Eur J Gen Pract; 2007; 13(4):239-41. PubMed ID: 18324507 [TBL] [Abstract][Full Text] [Related]
25. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Richter B; Derntl M; Marx M; Lercher P; Gössinger HD Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648 [TBL] [Abstract][Full Text] [Related]
26. Provision of potentially teratogenic medications to female veterans of childbearing age. Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159 [TBL] [Abstract][Full Text] [Related]
27. Antihypertensive medication changes and blood pressure goal achievement in a managed care population. Engel-Nitz NM; Darkow T; Lau H J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489 [TBL] [Abstract][Full Text] [Related]
28. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
29. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998 [TBL] [Abstract][Full Text] [Related]
30. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766 [TBL] [Abstract][Full Text] [Related]
31. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839 [TBL] [Abstract][Full Text] [Related]
32. A cohort study of antihypertensive medication use and breast cancer among Danish women. Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484 [TBL] [Abstract][Full Text] [Related]
33. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574 [TBL] [Abstract][Full Text] [Related]
34. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker]. Schindler C; Kosa M; Schröder J; Kirch W Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385 [No Abstract] [Full Text] [Related]
35. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415 [TBL] [Abstract][Full Text] [Related]
36. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region]. Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731 [TBL] [Abstract][Full Text] [Related]
38. Antihypertensive drugs and the risk of prostate cancer. Morote J; Planas J Eur Urol; 2011 Dec; 60(6):1309-10. PubMed ID: 21962717 [No Abstract] [Full Text] [Related]
39. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period. Formica RN; Friedman AL; Lorber MI; Bia MJ Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin II type 1 receptor blockade: high hopes sent back to reality? Grothusen A; Divchev D; Luchtefeld M; Schieffer B Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]